Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) (DeLOS II)

This study has been completed.
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Sanofi
Information provided by (Responsible Party):
ClinAssess, University of Leipzig
ClinicalTrials.gov Identifier:
NCT00508664
First received: July 27, 2007
Last updated: June 1, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)